perioperative management of glp-1 agonists A very important and practice-changing consensus statement from the British Journal Anaesthesia on of patients taking receptor such as semaglutide, tirzepatide, and liraglutide. The key message is TIRZEPATIDE Mechanism of action Quantity:6 Months Optimizes Fat Metabolism

perioperative management of glp-1 agonists A very important and practice-changing consensus statement from the British Journal Anaesthesia on of patients taking receptor such as semaglutide, tirzepatide, and liraglutide. The key message is TIRZEPATIDE Mechanism of action Quantity:6 Months Optimizes Fat Metabolism

TIRZEPATIDE Mechanism of action of tirzepatide GIP = glucose-dependent insulinotropic polypeptide; GLP-1 = glucagon-like peptide 1; LDL = low-density lipoprotein; HR = heart rate.

The international clinical development of efpeglenatide was stopped, despite being the only exendin derivative that, in a (terminated) phase 3 RCT, showed kidney benefit [HR 0.68 (95% CI 0.57–0.79)] and a reduction in the primary MACE outcome in T2DM patients with a history of CVD or CKD plus at least one other cardiovascular risk factor [57]

Optimizes Fat Metabolism

Quantity:6 Months

Will insurance cover prescription weight loss medication